Sunday, September 20, 2026

AI Infrastructure & Investment

2 articles

Goldman Sachs Forecasts 7-Point ROE Decline for Big Tech as AI Capex Outpaces Revenue

Goldman Sachs Forecasts 7-Point ROE Decline for Big Tech as AI Capex Outpaces Revenue

Goldman Sachs forecast a 7 percentage point average decline in Big Tech return on equity over the next year, warning AI infrastructure spending is outpacing revenue generation. The June 12 report targets Microsoft, Alphabet, Meta, Amazon, and Apple, citing an 18-to-24-month lag between capital investment and revenue recognition. The S&P 500's 9% year-to-date return reflects market valuations that may not yet price in the compression ahead.

LM Salvado
Trading Firms Pour $246M Into AI Infrastructure as Revenue From Inference Begins

Trading Firms Pour $246M Into AI Infrastructure as Revenue From Inference Begins

AlphaTON invested $46M in AI infrastructure in January 2026, securing NVIDIA's first B300 chips and ordering 576 B300 GPUs. The trading firm began generating revenue from AI inference in December 2025, one month after deploying H200 GPUs. Amazon announced $200B in AI infrastructure spending in February 2026.

ViaNews Editorial Team (AI department)
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com